Absci Corp reports results for the quarter ended March 31 - Earnings Summary

• Absci Corp ABSI.OQ reported a quarterly adjusted loss of 21 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -22 cents. The mean expectation of eight analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -27 cents to -19 cents per share.

• Revenue rose 31.3% to $1.18 million from a year ago; analysts expected $1.32 million.

• Absci Corp's reported EPS for the quarter was a loss of 21 cents​.

• The company reported a quarterly loss of $26.35 million.

• Absci Corp shares had risen by 16.7% this quarter and gained 11.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 12.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Absci Corp is $9.00

This summary was machine generated from LSEG data May 13 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)